The photodynamic effect of tetra-substituted N-methyl-pyridyl-porphine combined with the action of vancomycin or host defense mechanisms disrupts Staphylococcus epidermidis biofilms.
The skin commensal and opportunistic pathogen Staphylococcus epidermidis is an important cause of nosocomial infections. Virulence is attributable to formation of biofilm, which provides a microenvironment that protects the bacterium from attack by the host immune system and by chemotherapy. In this study we extended to S. epidermidis strategies previously aimed at treatment of S. aureus biofilms using photodynamic treatment (PDT) combined with chemotherapy or phagocytosis. A significant reduction in bacterial survival was observed when structurally distinct biofilms were exposed to the cationic porphyrin, tetra-substituted N-methyl-pyridyl-porphine (TMP), and simultaneously to visible light. Of note, the extent of biofilm clearance depended on its maturation stage: developing, young biofilms, were more sensitive towards PDT than mature biofilms. Furthermore, PDT-treated biofilms exposed to vancomycin or subjected to phagocytic action of whole blood were almost completely eradicated. The data we obtained establish that PDT combined with antibiotics or host defenses may also be a useful approach for the inactivation of S. epidermidis biofilms.
Department of Biochemistry, University of Pavia, Pavia, Italy.
Maria S
MS
Sbarra
Carla Renata
CR
Arciola
Antonella
A
Di Poto
Enrica
E
Saino
Holger
H
Rohde
Pietro
P
Speziale
Livia
L
Visai
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D018441:Biofilms / Q000187:drug effects*; D015169:Colony Count, Microbial; D003131:Combined Modality Therapy; D006801:Humans; D007113:Immunity, Innate; D008826:Microbial Sensitivity Tests; D010586:Phagocytes / Q000276:immunology / Q000382:microbiology; D010587:Phagocytosis; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000494:pharmacology*; D011166:Porphyrins / Q000494:pharmacology*; D013212:Staphylococcus epidermidis / Q000187:drug effects* / Q000254:growth & development / Q000276:immunology / Q000472:pathogenicity; D013997:Time Factors; D014640:Vancomycin / Q000494:pharmacology*; D014774:Virulence
D000900:Anti-Bacterial Agents; D017319:Photosensitizing Agents; D011166:Porphyrins; D014640:Vancomycin